Miguel Escobar/WFH
Aug 2, 2025, 16:50
Chromogenic Assays Underused in Females with Hemophilia A
The World Federation of Hemophilia (WFH) shared a post on X:
”A global survey of hemophilia providers shows that chromogenic assays versus one stage assays are ordered far less often in females than males—pointing to gaps in access, awareness, and clinical approach.
Read the full article.”
Article: Chromogenic vs one-stage assay to diagnose women and girls with hemophilia A—mapping global approaches and assessing challenges: communication from the SSCs of the ISTH
Authors: Lakshmi Srivaths, Joanna Larson, Karin Fijnvandraat, Jesus Ardila, Miguel Escobar
Find similar posts on Hemostasis Today.
-
May 28, 2026, 13:42Claudio Laudani: Balancing Ischemic and Bleeding Risk in AF with Coronary Disease
-
May 28, 2026, 13:30When it Comes to Stroke Care, Quality Matters – Duke Health
-
May 28, 2026, 13:29Natalie Johnson: Transforming PE Care Through Endovascular Innovation
-
May 28, 2026, 13:16Francisco Chacón-Lozsán: Anticoagulation Strategies for Complex ICU Patients
-
May 28, 2026, 12:57Ahmed Kardousha: Protecting Growth and Fertility in Transfusion-Dependent β-Thalassemia
-
May 28, 2026, 12:36Kabilan K L: Key Nursing Considerations for Abciximab Therapy
-
May 28, 2026, 12:17Astha Thakkar: Practical Approaches to Platelet Thresholds in ITP
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early